MADRID--(BUSINESS WIRE)--“This is a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system using PFA and Optical Coherence Reflectometry (OCR) to monitor and confirm the ...
HAYWARD, Calif., April 23, 2025--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationâ„¢ (nanosecond PFA or nsPFAâ„¢) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback